Study on fluvoxamine maleate sustained-release pellets and its compression technology
10.16438/j.0513-4870.2023-0593
- VernacularTitle:马来酸氟伏沙明缓释微丸及其压片技术的研究
- Author:
Ming-hui XU
1
,
2
;
Xing-yue ZHANG
3
;
Qiao DONG
1
,
2
;
Xia ZHAO
1
;
Yu-ru BU
3
;
Le-zhen CHEN
3
Author Information
1. Department of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China
2. Marine Biomedical Research Institute of Qing Dao, Qingdao 266071, China
3. Marine Biomedical Research Institute of Qing Dao, Qingdao 266071, China
- Publication Type:Research Article
- Keywords:
fluvoxamine maleate;
centrifugal-spherization method;
fluidized bed bottom-spray;
multi-unit sustained-release pellet;
micromeritic property;
italic>in vitro release
- From:
Acta Pharmaceutica Sinica
2024;58(2):439-447
- CountryChina
- Language:Chinese
-
Abstract:
In this study, fluvoxamine maleate sustained-release pellet system tablets were prepared and were used to evaluate their release behaviors in vitro. Fluvoxamine maleate pellets were prepared using centrifugal-spherization method and coated by fluidized bed as bottom-spray. The multi-unit sustained-release pellets and appropriate excipients for prescription volumes were mixed uniformly and then compressed to tablets. Screening and determining the optimal formulation of drug loaded pellets through L8 (24) Taguchi experiment. Using Minitab software to design a DOE experiment with 24 partial factors, including material temperature, fan speed, atomization pressure, and spray rate to optimize the bottom spray coating process. Taking monostearate glycerol ester with a particle size of 24-40 mesh as the main diluent for tableting to relieve the delamination phenomenon between pellets and excipients during tablet pressing and reduce mechanical damage to the coating film. By examining the powder fluidity indexes such as angle of repose, bulk density, tapped density, and Hausner ratio of mixed particles, it was found that the flowability and compressibility are good and suitable for direct compression. Evaluate the basic properties of the sustained-release tablets, investigate the in vitro release behavior and study the release mechanism. The results of in vitro release test showed that the self-made sustained-release tablets could disintegrate into independent pellet units in phosphate buffer at pH 6.8 and release slowly within 24 h, which conformed to the first-order drug release model. The fluvoxamine maleate sustained-release pellet system tablets meet the requirements of preparation design and has a great commercial prospect.
